Are You Compliant? What New Guidelines Mean for Neuromuscular Monitoring
Webinar hosted by CIHQ, recorded Aug 4, 2026
This recorded webinar explores the gap between guidelines and real-world practice, highlighting the clinical, operational, and compliance implications of neuromuscular monitoring. Viewers will gain practical insights into implementation strategies, stakeholder alignment, and how objective monitoring can support safer outcomes and quality improvement initiatives.
Center for Improvement in Healthcare Quality (CIHQ) hosted the webinar. The guest speaker was Michael Noble, Chief Marketing Officer at Senzime.
Learning Objectives
- Understand the clinical risks associated with residual neuromuscular blockade (rNMB) and its impact on patient outcomes
- Review current guideline recommendations for quantitative neuromuscular monitoring
- Identify gaps between guideline recommendations and current clinical practice
- Explore practical strategies for implementing quantitative monitoring across perioperative workflows
Watch video
Video recording of webinar "Are You Compliant? What New Guidelines Mean for Neuromuscular Monitoring" from Aug 4, 2026
We are here to guide you.
If you have any questions or would like to see how the TetraGraph system can seamlessly integrate into your workflows, we’d love to connect!